<i>De novo</i> hepatitis B virus infection after liver transplantation from anti-hepatitis B core antibody positive donor: a 20-year experience at a single center
نویسندگان
چکیده
Oranit Visutjindapon, Prawat Kositamongkol, Chutwichai Tovikkai, Yongyut Sirivatanauksorn, Somchai Limsrichamrern, Prawej Mahawithitwong, Wethit Dumronggittigule, Pholasith Sangserestid, Charnwit Assawasirisin. Korean J Transplant 2022;36:246. https://doi.org/10.4285/ATW2022.F-3853
منابع مشابه
Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
Exclusion of liver grafts from hepatitis B core antibody (anti-HBc) positive donors to prevent de novo hepatitis B virus (HBV) infection after liver transplantation is not feasible in areas highly endemic for HBV virus like Taiwan, where approximately 80% of adults are anti-HBc(+). The efficacy of lamivudine monotherapy to prevent de novo HBV infection after living donor liver transplantation (...
متن کاملDe novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibody
PURPOSE The use of hepatitis B core antibody (HBcAb)-positive grafts is increasing, especially where hepatitis B is endemic. However, this remains controversial because of the risk of development of de novo HBV infection. METHODS We collected information obtained between January 2000 and December 2012 and retrospectively analyzed data on 187 HBsAg-negative donors and recipients were analyzed ...
متن کاملLiver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
The use of livers from hepatitis B surface antigen-negative (HBsAg- )/hepatitis B core antibody-positive (HBcAb+ ) donors in liver transplantation (LT) for HBsAg(-) /HBcAb- recipients is still controversial because of a lack of standard antiviral prophylaxis and long-term follow-up. We present our 13-year experience with the use of HBcAb+ donor livers in HBcAb- recipients. Patients received pro...
متن کاملUtilization of hepatitis B core antibody-positive donor liver grafts.
BACKGROUND The inclusion of hepatitis B core antibody-positive (HBcAb+) liver donors is a strategy utilized to increase organ availability. This study examined HBcAb+ transplantation practices to identify specific factors influencing outcomes. METHODS Twenty-five HBcAb+ liver transplants were identified retrospectively among 868 adult transplants performed between 1 January 1997 and 31 Decemb...
متن کاملAdult Living Donor Liver Transplantation Using Hepatitis B Core Antibody-Positive Grafts in Korea, a Hepatitis B-endemic Region
BACKGROUND/AIMS The exclusion of hepatitis B core antibody (HBcAb)-positive donors from liver transplants (LTs) due to the risk of transmitting hepatitis B virus (HBV) does not appear to be practical in Korea, where hepatitis B is endemic. This study assessed the risk of de novo HBV infection in hepatitis B surface antigen (HBsAg)-negative LT recipients receiving a liver from HBcAb-positive don...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Korean journal of transplantation
سال: 2022
ISSN: ['2671-8790', '2671-8804']
DOI: https://doi.org/10.4285/atw2022.f-3853